Zemcelpro® (dorocubicel) receives NUB Status 1 in Germany
MONTREAL, Feb. 16, 2026 /PRNewswire/ — ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and metabolic fitness, and its wholly owned subsidiary Cordex Biologics (Cordex), announced that Zemcelpro® (dorocubicel),
